photo_2021-05-06_10-28-06_edited.jpg

PRESS

ContiVir in the media

2021

· Max Planck Institute Magdeburg
"Innovation Prize 2021 of the German BioRegions awarded to ContiVir"
ContiVir is awarded with the 2021 Innovation Prize of the German Bioregions with the topic "Purification tool to tackle vaccine bottlenecks".

​· BIO Deutschland

"Innovationspreis der BioRegionen: angewandte Forschung in der Impf- und Wirkstoffforschung sowie Biomedizintechnik ausgezeichnet (German only)"
ContiVir is awarded with the 2021 Innovation Prize of the German Bioregions with the topic "Purification tool to tackle vaccine bottlenecks".

· National Geographic

"The world needs more vaccines, faster. A tiny tube could make all the difference"
Felipe Tapia discusses how ContiVir's Continuos Tubular Bioreactor (CTB) can revolutionize vaccine manufacturing.

· Max Planck Institute Magdeburg

"ContiVir offers purification tool to tackle viral gene therapy manufacturing bottlenecks"
Pavel Marichal and Julian Lopez discuss SXC's advantages as a purification tool for manufacturing of adeno adeno-associated virus (AAV), widely used in human gene therapy.

2020

· BBC News
"Coronavirus: cómo son las 6 vacunas contra el virus que ya se están probando en humanos y qué países están ganando la carrera" (Spanish only)
Felipe Tapia discusses the challenges on the global manufacturing of a coronavirus vaccine.

· Investieren in Sachsen-Anhalt
"ContiVir: Zwei neue Technologien für die Herstellung und Aufreinigung von viralen Vektoren werden kombiniert" (German only) 
Pavel Marichal and Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

· Max Planck Institute Magdeburg
"Scientists of the Bioprocess Engineering group receive a €1.1 Million Startup Grant to Advance Gene Therapy Manufacturing"
Pavel Marichal and Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

· Nature.com
"If a coronavirus vaccine arrives, can the world make enough?"
Felipe Tapia comments on the production of a viral coronavirus vaccine.

· Cell & Gene Therapy Insights
"Suspension systems in continuous viral vector production processes"
Felipe Tapia discusses the different options for continuous culture of suspension cells for the production of virus particles.